Content
Pre-March Corn Stock Update
Article By:
Jerry Gidel
Read
Monday, March 27, 2023 3:59 AM EDT
The corn market’s focus will be split on March 31 between the USDA’s prospective plantings & quarterly stocks reports next week. The US quarterly stocks are important updates on how US demand has performed during the 1st half of the crop year.
In this article: CORN
Overseas Buyers Scoop Up U.S. Shares - Bullish Or Bearish?
Article By:
ForexCycle
Read
Sunday, March 26, 2023 11:00 AM EDT
No crowd buys stocks of other countries intelligently. For decades, heavy foreign buying in the U.S. stock market has served as an excellent indicator of major tops.
Deposits On The Move
Article By:
Menzie Chinn
Read
Sunday, March 26, 2023 5:23 AM EDT
Higher rates as a source of instability for deposits and Treasury holdings is most unusual compared to previous banking crises where the source of instability was credit losses putting downward pressure on the illiquid side of banks’ balance sheets.
Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million
Article By:
ChinaBio® Today
Read
Saturday, March 25, 2023 2:19 PM EDT
HighlightLL Pharma out-licensed rights to its novel oral, brain-penetrating, dual inhibitor to New Haven’s Biohaven in a deal worth up to $970 million. Biohaven will have global rights to the product for $10 million upfront and $10 million in equity.
SVB, SIFIs, Dodd-Frank, EGRRCPA, HQLA And The LCR
Article By:
Menzie Chinn
Read
Sunday, March 19, 2023 10:00 AM EDT
One major question posed by recent events is whether the issues SVB faced would’ve been caught had EGRRCPA not been passed which raised the threshold for what qualifies as a SIFI.
In this article: SIVBQ
UBS Seeks Government Backstop As It Rushes To Finalize Credit Suisse Takeover Deal As Soon As Tonight
Article By:
Tyler Durden
Read
Saturday, March 18, 2023 4:15 PM EDT
So much can change in just 48 hours. Late on Thursday, it appeared that UBS was opposed to a combination with Credit Suisse. Then, on Friday, both banks appeared to change their minds. Now, it seems a deal is inevitable.
Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement
Article By:
ChinaBio® Today
Read
Saturday, March 18, 2023 2:40 PM EDT
Livzon Pharmaceutical Group entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease therapy from Onconic Therapeutics. Meanwhile, Gracell Biotech announced that it had entered an unusual global deal with Seagen.
BMW To Pause Raising Prices On Premium Vehicles After Years Of 40% Increases
Article By:
Tyler Durden
Read
Saturday, March 18, 2023 2:00 PM EDT
BMW has announced it's going to stop raising prices on its premium vehicles after 2023, marking what could be a top in auto prices as global supply continues to swell and the average consumer is tapped with debt.
Eurozone Industrial Production Ticks Up In January
Article By:
ING Economics
Read
Wednesday, March 15, 2023 7:38 AM EDT
Production rose 0.7% between December 2022 and January 2023 but maintains a broad trend of stagnation. Strong German and Irish production figures mask weakness elsewhere in Europe.
In this article: EZU
Icahn Reacts Audaciously To Illumina’s Audacity
Article By:
Lipper Alpha Insight
Read
Wednesday, March 15, 2023 7:13 AM EDT
Carl Icahn has correctly diagnosed what ails Illumina, but he is prescribing an overly aggressive treatment. The pushy billionaire wants three board seats at the biotechnology company, after it overpaid for Grail and took on too much regulatory risk.
In this article: ILMN
Aftershock Life After Silicon Valley Bank
Article By:
Michael Lebowitz
Read
Wednesday, March 15, 2023 6:28 AM EDT
While headlines of bank failures and bailouts consume the media, few are contemplating the economic and financial aftershocks that will follow.
In this article: KRE
Corporatism Is Not Capitalism
Article By:
Martin Hutchinson
Read
Wednesday, March 15, 2023 5:38 AM EDT
The Federal Trade Commission is proposing to ban non-compete agreements, which prevent employees from working for a competitor for an often lengthy period after their departure and are applied to some 30 million U.S. employees.
SVB: Bank Insolvency Is A Four Letter Word
Article By:
Mad Genius Economics
Read
Wednesday, March 15, 2023 4:58 AM EDT
SVB is the tip of the iceberg, will not remain contained, and is indicative of systemic issues.
FX Daily: A Nervous Calm Returns To FX Markets
Article By:
ING Economics
Read
Wednesday, March 15, 2023 4:52 AM EDT
Measures of stress in financial markets have eased back from their spike on Monday, but remain elevated. Investors remain nervous over deposit flight from the less well-scrutinized US banks and whether any more of those banks will run into trouble.